About Masatoshi Hagiwara
Masatoshi Hagiwara is a chief scientific officer, director of the board at BTB Therapeutics.
Experience
This experience comes from Masatoshi Hagiwara's profile and from SEC filings. For roles taken from filings, the years are when the filings name Masatoshi Hagiwara in the role, so the role may have started earlier or lasted longer.
BTB Therapeutics, Inc. Current
Chief Scientific Officer, Director of the Board
Founder/ Chief Scientific Officer (2020 – Present)
2020 – Present · Escondido, CA
Develops non-opioid pain medicines and treatments for rare genetic diseases and cancer.
KU
Kyoto University (京都大学) Current
Professor and Chair, Department of Drug Discovery Medicine
2010 – Present
TU
Tokyo Medical and Dental University
Professor, School of Biomedical Sciences
1997 – 2010
SS
Salk Institute for Biological Studies
Postdoctoral Fellow
1991 – 1992
Key Colleagues at Startups
The people Masatoshi Hagiwara works with at each company, as listed on that company's latest Form D.
BTB Therapeutics, Inc. · Form D/A, Aug 12, 2026
Takashi Kiyoizumi
CEO, Director of the Board
David Snyder
Director of the Board
Nobuhiro Yagi
Director of the Board
SY
Sidney Yee
Director